Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2012
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102395570A Aminopyrimidinamides as pest control agents
03/28/2012CN102395567A Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
03/28/2012CN102391255A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
03/28/2012CN102391252A Novel hindered amine group-contained benzotriazole light stabilizer
03/28/2012CN102391251A Chemokine receptor antagonists
03/28/2012CN102391250A Dabigatran compound and preparation method and medicinal composition thereof
03/28/2012CN102391249A 3,5-dichloropyridyl pyrazole amide compound and application thereof
03/28/2012CN102391248A O-aminobenzene carbonitrile compound as well as preparation method and usages thereof
03/28/2012CN102391191A Piperazine di-thiocarboxylic acid ester derivative of 2,4-di-aminoquinazoline, as well as preparation method and anti-tumor application of the derivative
03/28/2012CN102391171A Novel Substituted 3-Sulfur Indoles
03/28/2012CN102391168A Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
03/28/2012CN102391107A Method for preparing gallic acid quinolone drug salt and preparation method thereof
03/28/2012CN101646654B Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
03/28/2012CN101550132B Arylvinylazacycloalkane compounds and methods of preparation and use thereof
03/28/2012CN101189224B Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenyl amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
03/27/2012US8143421 Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/27/2012US8143409 X ray powder diffraction peaks at 10.5, 18.0, 18.4, 19.4, 21.1, 21.7, 22.9, 23.3, 27.1 and 31.6; easy handling and storage; bioavailability, release times, solubility
03/27/2012US8143408 N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
03/27/2012US8143400 Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine hydrochloride
03/27/2012US8143300 Inhibitors of cellular necrosis
03/27/2012US8143294 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors
03/27/2012US8143293 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
03/27/2012US8143292 N-Thio-anthranilamid compounds and their use as pesticides
03/27/2012US8143291 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
03/27/2012US8143290 Chemical compounds 572
03/27/2012US8143289 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/27/2012US8143287 Thrombopoietin mimetics
03/27/2012US8143286 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione)
03/27/2012US8143285 Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
03/27/2012US8143284 Poly(ADP-ribose)polymerase inhibitors
03/27/2012US8143282 Heterocyclic compounds
03/27/2012US8143281 vasopressin receptor antagonists; indol-3-yl-carbonyl-piperidine-benzopyrrolone, -benzoxazolone and -benzotriazole derivatives; antidepressants, anxiolytic agents; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
03/27/2012US8143278 Organic compounds
03/27/2012US8143269 Inhibitors of store operated calcium release
03/27/2012US8143260 Tricyclic amine compound
03/27/2012US8143257 Substituted phenols as active agents inhibiting VEGF production
03/27/2012US8143246 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
03/27/2012US8143238 Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin D compound
03/27/2012US8143057 Chelating agents and highly luminescent and stable chelates and their use
03/27/2012CA2554642C Bicyclic carbonyl amino derivatives as chemokine receptor antagonists
03/27/2012CA2540541C Alkoxy substituted imidazoquinolines
03/27/2012CA2447091C Methods for the treatment and prevention of pain using stress-activated protein kinase
03/27/2012CA2431487C Oligo or polyalkylene glycol-coupled thrombin inhibitors
03/22/2012WO2012037498A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
03/22/2012WO2012037411A2 Estrogen receptor modulators and uses thereof
03/22/2012WO2012037269A1 Substituted bipyridines for use in organic light-emitting devices
03/22/2012WO2012037204A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012036278A1 Glycine transporter inhibitor
03/22/2012WO2012036268A1 Glycine transporter inhibitory substance
03/22/2012WO2012036253A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
03/22/2012WO2012035421A2 Pyridine compounds and the uses thereof
03/22/2012WO2012035124A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
03/22/2012WO2012035078A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
03/22/2012WO2012035011A1 Pesticidal arylpyrrolidines
03/22/2012WO2012034961A1 Pyridine compounds for controlling invertebrate pests i
03/22/2012WO2012034960A1 Pyridine compounds for controlling invertebrate pests ii
03/22/2012WO2012034957A1 Pesticidal pyrroline n-oxide derivatives
03/22/2012WO2012034403A1 Fluoromethoxypyrazole anthranilamide compounds, synthesization methods and uses thereof
03/22/2012WO2012034363A1 Compounds of hedgehog pathway inhibitors, pharmaceutical compositions containing the same and uses thereof
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071654 Aryl aniline derivatives as beta2 adrenergic receptor agonists
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071652 Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof
03/22/2012US20120071651 Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives
03/22/2012US20120071632 Lenalidomide and Thalidomide Immunoassays
03/22/2012US20120071594 Polytriazinyl compounds as flame retardants and light stabilizers
03/22/2012US20120071517 2-pyridinylethylcarboxamide derivatives and their use as fungicides
03/22/2012US20120071516 Compounds that modulate intracellular calcium
03/22/2012US20120071515 Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
03/22/2012US20120071513 Compositions and Their Use as Anti-Tumor Agents
03/22/2012US20120071512 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/22/2012US20120071509 process
03/22/2012US20120071508 Cyclic-alkylamine derivatives as inhibitors of the interaction between mdm2 and p53
03/22/2012US20120071506 Methods for treating cns disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles
03/22/2012US20120071496 Aminopyrimidinamides As Pest Control Agents
03/22/2012US20120071491 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
03/22/2012US20120071482 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
03/22/2012US20120071478 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071472 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012US20120071461 Substituted Benzamide Compounds
03/22/2012US20120071325 Use of amide compound for promoting plant root growth
03/22/2012US20120069418 Electrochromic formulation, method for the production thereof, and organic electrochromic component
03/22/2012US20120068170 Materials for organic electroluminescent devices
03/22/2012CA2812089A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012CA2811479A1 Pyridine compounds and the uses thereof
03/22/2012CA2811080A1 Heterocyclic compound
03/22/2012CA2810094A1 Estrogen receptor modulators and uses thereof
03/21/2012EP2431370A1 Monoacylated 1,2-diaminocycloalkanes
03/21/2012EP2431365A1 Azetidine compound and medicinal use thereof
03/21/2012EP2431357A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
03/21/2012EP2431035A1 Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
03/21/2012EP2430014A1 Antiviral compounds
03/21/2012EP2430013A1 Heteroaryl compounds as pikk inhibitors
03/21/2012EP2430012A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2430011A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/21/2012EP2430002A1 Process for the preparation of a compound useful as an inhibitor of tafia
03/21/2012EP2430000A2 Fungicide pyrazole carboxamides derivatives
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 1080